Lisa M. Ebert

North Terrace
Adelaide, SA 5000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors.

A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors.

Journal: Clinical & translational immunology

Published: February 02, 2026

Tumors located in the brain impair the frequency and phenotype of dendritic cells in blood and tumor.

Tumors located in the brain impair the frequency and phenotype of dendritic cells in blood and tumor.

Journal: iScience

Published: October 14, 2025

Patient Views on a Pre-treatment Blood Test to Predict Outcomes Following PD-1 Inhibitor Therapy: A Qualitative Study.

Patient Views on a Pre-treatment Blood Test to Predict Outcomes Following PD-1 Inhibitor Therapy: A Qualitative Study.

Journal: International journal of behavioral medicine

Published: January 23, 2025

EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses.

EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses.

Journal: Journal for immunotherapy of cancer

Published: July 18, 2024

Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy.

Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy.

Journal: Immunology and cell biology

Published: June 27, 2024

Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.

Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.

Journal: Journal for immunotherapy of cancer

Published: April 28, 2024

Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy.

Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy.

Journal: Clinical & translational immunology

Published: November 12, 2023

Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma.

Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma.

Journal: Clinical & translational immunology

Published: October 30, 2023

Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma.

Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma.

Journal: Science advances

Published: October 25, 2023

Desmoglein-2 as a cancer modulator: friend or foe?

Desmoglein-2 as a cancer modulator: friend or foe?

Journal: Frontiers in oncology

Published: October 25, 2023

Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in Australia.

Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in Australia.

Journal: Immunology and cell biology

Published: September 11, 2023

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma.

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma.

Journal: Frontiers in immunology

Published: July 19, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026